SOTAVerified
|
Agents
Browse
Leaderboard
About
Tasks
›
Prognosis
Prognosis
Predict the remaining useful life
Papers
Recently Added
Most Hyped
Most Active
Needs Verification
Most Verified
Showing 801–810 of 900 papers
Title
Date
Tasks
Status
Hype
Score
Beyond attention: deriving biologically interpretable insights from weakly-supervised multiple-instance learning models
Sep 7, 2023
Multiple Instance Learning
Prognosis
—
Unverified
0
0
Beyond COVID-19 Diagnosis: Prognosis with Hierarchical Graph Representation Learning
Jan 1, 2021
Computed Tomography (CT)
COVID-19 Diagnosis
—
Unverified
0
0
Beyond Feature Importance: Feature Interactions in Predicting Post-Stroke Rigidity with Graph Explainable AI
Apr 10, 2025
Feature Importance
Graph Attention
—
Unverified
0
0
Beyond Segmentation: Confidence-Aware and Debiased Estimation of Ratio-based Biomarkers
May 26, 2025
Decision Making
Prognosis
—
Unverified
0
0
BioFace3D: A fully automatic pipeline for facial biomarkers extraction of 3D face reconstructions segmented from MRI
Oct 1, 2024
Prognosis
—
Unverified
0
0
BOston Neonatal Brain Injury Data for Hypoxic Ischemic Encephalopathy (BONBID-HIE): II. 2-year Neurocognitive Outcome and NICU Outcome
Nov 5, 2024
Prognosis
—
Unverified
0
0
BPE and computer-extracted parenchymal enhancement for breast cancer risk, response monitoring, and prognosis
Sep 14, 2018
Prognosis
—
Unverified
0
0
Brain MRI-based 3D Convolutional Neural Networks for Classification of Schizophrenia and Controls
Mar 14, 2020
BIG-bench Machine Learning
General Classification
—
Unverified
0
0
Brain MRI study for glioma segmentation using convolutional neural networks and original post-processing techniques with low computational demand
Jul 15, 2022
Brain Tumor Segmentation
Medical Image Analysis
—
Unverified
0
0
Brain Tumor Segmentation using an Ensemble of 3D U-Nets and Overall Survival Prediction using Radiomic Features
Dec 3, 2018
Brain Segmentation
Brain Tumor Segmentation
—
Unverified
0
0
Show:
10
25
50
← Prev
Page 81 of 90
Next →
No leaderboard results yet.